REACT: a randomized trial to assess the efficacy and safety of clazosentan for preventing clinical deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
第一作者:
Stephan A,Mayer
第一单位:
1Neurocritical Care and Emergency Neurological Services, Westchester Medical Center Health Network, Valhalla, New York.;2Department of Neurology and Neurosurgery, New York Medical College, New York, New York.
作者:
主题词
人类(Humans);男(雄)性(Male);中年人(Middle Aged);女(雌)性(Female);蛛网膜下腔出血(Subarachnoid Hemorrhage);双盲法(Double-Blind Method);吡啶类(Pyridines);二恶烷类(Dioxanes);嘧啶类(Pyrimidines);脑缺血(Brain Ischemia);磺胺类(Sulfonamides);四唑类(Tetrazoles);老年人(Aged);前瞻性研究(Prospective Studies);治疗结果(Treatment Outcome);成年人(Adult);血管痉挛, 颅内(Vasospasm, Intracranial)
DOI
10.3171/2024.4.JNS232191
PMID
39126720
发布时间
2025-01-03
- 浏览0

Journal of neurosurgery
98-109页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文